These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28570259)

  • 1. Propensity-Score Matched Comparison of the Cera PFO Occluder With the Amplatzer PFO Occluder for Percutaneous Closure of Patent Foramen Ovale Without Echocardiographic Guidance.
    Ulmi M; Praz F; Siontis GCM; Wahl A; Windecker S; Mattle HP; Meier B
    J Invasive Cardiol; 2017 Aug; 29(8):280-284. PubMed ID: 28570259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Contrast Echocardiography and Clinical Follow-Up after Percutaneous Closure of Patent Foramen Ovale Using Two Different Atrial Septal Occluder Devices.
    Scalise F; Auguadro C; Sorropago G; Sorropago A; Novelli E; Finizio M; Specchia G
    J Interv Cardiol; 2016 Aug; 29(4):406-13. PubMed ID: 27338839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplatzer or Figulla Flex II Occluder: a comparative study of outcomes after transcatheter patent foramen ovale closure.
    Toggweiler S; Moccetti F; Conrad N; Loretz L; Madanchi M; Bossard M; Attiger-Toller A; Cuculi F; Wolfrum M
    J Invasive Cardiol; 2024 Apr; 36(4):. PubMed ID: 38412438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiography vs transesophageal echocardiography-guided patent foramen ovale closure: A propensity score matched analysis of a two-center registry.
    Scacciatella P; Meynet I; Giorgi M; Biava LM; Matranga I; Biasco L; Omedè P; Orzan F; Gaita F
    Echocardiography; 2018 Jun; 35(6):834-840. PubMed ID: 29457261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
    Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
    Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
    Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
    Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
    Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F
    EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
    Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
    Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: procedural and follow-up results after implantation of the Amplatzer®-occluder device.
    Fischer D; Haentjes J; Klein G; Schieffer B; Drexler H; Meyer GP; Schaefer A
    J Interv Cardiol; 2011 Feb; 24(1):85-91. PubMed ID: 20735710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism.
    Wahl A; Jüni P; Mono ML; Kalesan B; Praz F; Geister L; Räber L; Nedeltchev K; Mattle HP; Windecker S; Meier B
    Circulation; 2012 Feb; 125(6):803-12. PubMed ID: 22238228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Outcomes after Device Closure with Transseptal Puncture and Standard Technique in Patients with Patent Foramen Ovale and Ischemic Events.
    Moon J; Kang WC; Kim S; Kim MG; Oh PC; Park YM; Chung WJ; Choi DY; Lee JY; Lee YB; Hwang HY; Ahn T
    J Interv Cardiol; 2016 Aug; 29(4):400-5. PubMed ID: 27282763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
    Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
    Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
    Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
    Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A propensity score-matched comparison between Cardia and Amplatzer PFO closure devices - insights from the SOLUTION registry (Swiss percutaneOus patent foramen ovale cLosUre in recurrent clinical events prevenTION).
    Puricel S; Arroyo D; Goy JJ; Praz F; Palhais N; Wahl A; Stauffer JC; Togni M; Berger A; Meier B; Cook S
    EuroIntervention; 2015 Jun; 11(2):230-7. PubMed ID: 24830681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
    Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
    BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale closure by using transesophageal echocardiography for cryptogenic stroke: single center experience in 132 consecutive patients.
    Han Y; Zhang X; Zhang F
    J Cardiothorac Surg; 2020 Jan; 15(1):11. PubMed ID: 31918738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural Outcomes of Fluoroscopy-Guided Patent Foramen Ovale Closure With Selective Use of Intracardiac Echocardiography.
    Barker M; Muthuppalaniappan AM; Abrahamyan L; Osten MD; Benson LN; Bach Y; Ma J; Abraha N; Horlick E
    Can J Cardiol; 2020 Oct; 36(10):1608-1615. PubMed ID: 32610094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
    Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
    Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.